Vervoort, Stephin J.
Devlin, Jennifer R.
Kwiatkowski, Nicholas
Teng, Mingxing http://orcid.org/0000-0001-6574-1764
Gray, Nathanael S. http://orcid.org/0000-0001-5354-7403
Johnstone, Ricky W. http://orcid.org/0000-0001-7053-9237
Article History
Accepted: 9 September 2021
First Online: 21 October 2021
Competing Interests
: The Johnstone laboratory receives research support from Roche, BMS, AstraZeneca and MecRx. R.W.J. is a scientific consultant and shareholder in MecRx. N.S.G. is a founder, science advisor and equity holder in C4, Syros, Soltego, B2S, Jengu, Allorion, EoCys and Larkspur Pharmaceuticals. The Gray laboratory receives or has received research funding from Novartis, Takeda, Astellas, Taiho, Janssen, Kinogen, Voronoi, Arbella, Deerfield and Sanofi. N.S.G. and N.K. are inventors on a patent application covering THZ1, which is licensed to a company co-founded by N.S.G.. N.K. is an employee of Kymera Therapeutics. S.J.V., J.R.D. and M.T. declare no competing interests.